Each vial contains 5 mg or 10 mg of idarubicin hydrochloride and 50 mg or 100 mg of Lactose N.F. as an orange-red, Iyophilized powder. Slightly soluble in water. Sparingly soluble in methanol. Please see Section 7 for additional compatibility information.
Results are from three separate experiments.
Colonies were counted on the sixth day. The median inhibitory dose was determined from dose-effect lines. The data represent the means of at least two separate experiments. This is of particular interest since L1210 leukemia is known to have partial natural resistance to anthracyclines. Value reported as mean survival time.